Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruschettini SrlfiledCriticalBruschettini Srl
Priority to IT19252/85ApriorityCriticalpatent/IT1199653B/it
Publication of IT8519252A0publicationCriticalpatent/IT8519252A0/it
Priority to BE0/215037Aprioritypatent/BE902453A/fr
Application grantedgrantedCritical
Publication of IT1199653BpublicationCriticalpatent/IT1199653B/it
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0012—Galenical forms characterised by the site of application
A61K9/0048—Eye, e.g. artificial tears
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
Health & Medical Sciences
(AREA)
Life Sciences & Earth Sciences
(AREA)
Chemical & Material Sciences
(AREA)
Medicinal Chemistry
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
Ophthalmology & Optometry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
IT19252/85A1985-01-281985-01-28Composizione farmaceutica a carattere di collirio ad azione antiinfiammatoria,e procedimento per la sua preparazione
IT1199653B
(it)
Procedimento per la preparazione di etofibrato o sostanze di pari osimili caratteristiche, inmicrogranuli-ritardo e prodotto ottenuto con tale procedimento
N-[4-(3-amminopropil)amminobutil]2,2-diidrossiotanammide come immuno -stimolante ed intermedio per laproduzione di sostanze carcinostati che, e procedimento per la sua preparazione
Composto ad attivita'analgesica e antiinfiammatoria ad azione protratta, procedimento per la sua preparazione e relative composizioni farmaceutiche.